Microsoft (MSFT) just delivered a price move that got everyone's attention. The stock surged roughly 14% in a single week, its strongest performance since 2007. Software stocks broadly logged their best week in 25 years during the same stretch, driven by blowout tech earnings and easing macro pressure.
Markets celebrated. The health score didn't budge.
That's not a glitch. That's the whole point. MSFT's health score stayed flat because the underlying business didn't change in seven days. The fundamentals that drive it take quarters to build. And right now, those fundamentals are among the strongest in the entire Stoxcraft universe.
Microsoft is one of the top-rated stocks on the platform. Its health score of 8.6 out of 10 places it in the top 10% of all companies tracked across more than 3,900 stocks. Its performance score of 9.9 out of 10 puts it in the top 1% across all time horizons measured. Together, those numbers reflect a company that has compounded at elite levels for years, through bull markets, corrections, and every AI narrative in between.
What Microsoft's health score reveals
Microsoft's health score of 8.6 out of 10 is one of the highest readings in the entire Stoxcraft universe. Within the Information Technology sector, it ranks at the very top. This score is built on quarterly balance sheet and income data. It doesn't care what the stock did last Tuesday.
The score reflects a business that generates cash at a scale most companies will never approach. That's the dominant force behind the reading. But there are also weaker spots worth naming, and understanding both is how you use this tool correctly.
The extraordinary cash flow behind Microsoft's health rating
Microsoft's operating cash flow runs at approximately $136 billion on a trailing twelve-month basis. That is the engine behind almost everything else. Free cash flow per share sits at $10.50, a figure that funds dividends, buybacks, and now one of the largest AI infrastructure programs in corporate history, all at the same time.
Net profit margin comes in at 35.7%, which is significantly above the sector median. The balance sheet is also stress-tested with an Altman Z-Score of 10.1. That level signals very low financial distress risk, even as the company commits $190 billion in capital expenditures this year.
The one area that prevents a perfect health reading is the Piotroski score, which sits at 5 out of 9. A midrange reading here reflects the tension between strong earnings quality and rapidly rising capex. That is not a red flag. It is a calibration: the business is spending aggressively to build future revenue at the cost of short-term cash flow efficiency.
What Q3 FY2026 earnings confirmed about Microsoft's fundamentals
Microsoft's earnings for Q3 FY2026 validated what the health score had been showing. Revenue reached $82.9 billion, up 18% year over year. Operating income rose 20% to $38.4 billion. Operating margin came in at 46.3%, ahead of guidance. EPS hit $4.27 against a $4.06 consensus, a beat of nearly 5%.
None of that moved the health score. It simply confirmed what the fundamentals had already said for months.
How Microsoft's performance compares to top-performing stocks in 2026
Microsoft's performance score of 9.9 out of 10 is the highest rating on the Stoxcraft scale. It reflects multi-year outperformance versus major indices including the S&P 500 and the Nasdaq, measured across one, three, and five-year horizons.
That score didn't spike after last week's rally. It was already at the ceiling. The reason is that long-term relative returns carry the most weight in this score. MSFT has been beating its benchmarks consistently for years, and that track record doesn't disappear when the stock has a rough quarter.
Multi-year outperformance versus the S&P 500 and Nasdaq
Before the recent drawdown, Microsoft had spent years compounding ahead of both major indices. The five-year and three-year relative performance are the two most heavily weighted horizons in this score. MSFT's track record over those periods reflects a company that turned Azure into a dominant cloud platform while simultaneously monetizing AI, Office 365, and enterprise software at scale.
That consistency is exactly why the performance score stays near the ceiling even when the stock pulls back 20% in a bad quarter. The long-term revenue machine keeps running regardless of short-term momentum.
Azure and AI revenue extending the outperformance case
Azure grew 40% year over year in Q3, beating Microsoft's own guidance of 37% to 38%. The AI business now runs at $37 billion annualized, up 123% from a year earlier. Commercial remaining performance obligation reached $627 billion, up 99%, with roughly a quarter of that converting to revenue over the next 12 months.
These are the numbers that built the performance score over time, and they're what will keep it elevated going forward. The revenue engine is compounding. The score reflects that.
What the entry signal is showing after Microsoft's 14% rally
Before the Q3 results, MSFT was down around 14% year to date, sitting more than 30% below its 52-week high of $555. RSI had drifted toward oversold. Short-term momentum was negative. The entry signal was firmly in unattractive territory.
Post-earnings, the technical picture shifted materially. RSI recovered back toward neutral. MACD turned positive. The trend signal moved from downtrend to recovering uptrend. The entry attractiveness improved toward neutral-to-favorable, driven by the momentum reversal and analyst consensus that still points to meaningful upside.
The stock still trades roughly 25% below its 52-week high at current prices near $410. That distance creates upside headroom in analyst models. Price targets across major firms range from $450 to $515, implying 10% to 25% potential upside from here.
The key signals to watch going into Q4 FY2026 earnings, expected July 29, 2026, are:
- Azure growth: management guided 39% to 40% for Q4, which would mark a second consecutive quarter of acceleration
- AI revenue run rate: if the $37 billion annualized figure keeps growing at triple-digit rates, the valuation story shifts quickly
- Free cash flow trajectory: $190 billion in capex is a significant commitment; how cash flow holds up under that pressure is the critical test
MSFT's overall rating and what to watch for Q4
Microsoft's overall rating on Stoxcraft sits among the highest on the entire platform. The elite health profile and top-tier long-term performance combine to push the total rating into the very highest range. The risk profile, elevated by this year's volatility and the ongoing capex program, keeps it from a perfect score. But the combination puts MSFT well above the vast majority of stocks tracked.
For investors asking whether the post-rally moment is still a valid entry point: the fundamentals say yes, the business is exceptional. The technical signals say the trend has turned. But a 14% weekly gain means short-term momentum risk is real for anyone entering right here. The smarter approach is to watch the Q4 Azure number before adding meaningful exposure.
The deeper takeaway is this: the health score held steady through a brutal year-to-date drawdown and through last week's massive recovery. That is exactly what a fundamentals-based score is supposed to do. It tells you about the business, not the noise.
For investors tracking other high-quality tech names, Nvidia (NVDA) sits at the top of the semiconductor sector on Stoxcraft. Amazon (AMZN) is another platform-level compounder worth comparing across health and performance dimensions. The AI infrastructure demand driving Microsoft's cloud growth is explored further in this piece on the chip boom.
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Stoxcraft scores are quantitative indicators, not buy or sell recommendations. All scores are based on Financial Modeling Prep (FMP) data. Past performance is not indicative of future results. Always conduct your own research before making investment decisions.
